Literature DB >> 29661053

Differential Diagnosis of Sinonasal Lymphoma and Squamous Cell Carcinoma on CT, MRI, and PET/CT.

Seok-Hyun Kim1, Sue-Jean Mun1, Hak-Jin Kim2, Seon Lin Kim1, Sung-Dong Kim1, Kyu-Sup Cho3.   

Abstract

Objective The purpose of this study was to analyze computed tomography (CT) and magnetic resonance (MR) images and to evaluate the maximum standardized uptake value (SUV max) of positron emission tomography (PET)/CT parameters between sinonasal non-Hodgkin's lymphoma (NHL) and squamous cell carcinoma (SCC), knowing the imaging features that distinguish sinonasal NHL from SCC. Study Design Case series with chart review. Setting University tertiary care facility. Subjects and Methods We analyzed the features on CT, MR imaging, and PET/CT of 78 patients diagnosed with sinonasal NHL or SCC histopathologically. The CT (n = 34), MRI (n = 25), and PET/CT (n = 33) images of 39 patients with sinonasal NHL and the CT (n = 38), MR (n = 28), and PET/CT (n = 31) images of 39 patients with SCC were evaluated. The sinonasal NHL was diagnosed as natural killer/T-cell lymphoma (n = 28) and diffuse large B-cell lymphoma (n = 11). Results Patients with sinonasal NHL had a larger tumor volume and higher tumor homogeneity than patients with SCC on T2-weighted and postcontrast MR images. Most of the sinonasal NHL and SCC showed a high degree of enhancement. The apparent diffusion coefficient (ADC) values and adjacent bone destruction were significantly lower in sinonasal NHL than in SCC. However, cervical lymphadenopathy, Waldeyer's ring involvement, and PET/CT SUV max showed no significant differences between sinonasal NHL and SCC. Conclusion CT and MR images of sinonasal masses showing a bulky lesion, marked homogeneity, and low ADC values without adjacent bone destruction are more suggestive of sinonasal NHL than SCC.

Entities:  

Keywords:  carcinoma; lymphoma; magnetic resonance imaging; non-Hodgkin; paranasal sinus neoplasms; positron emission tomography; spiral computed; squamous cell; tomography

Mesh:

Year:  2018        PMID: 29661053     DOI: 10.1177/0194599818770621

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  7 in total

1.  Positron emission computed tomography and magnetic resonance imaging features of sinonasal small round blue cell tumors.

Authors:  Kerem Ozturk; Mehmet Gencturk; Emiro Caicedo-Granados; Faqian Li; Zuzan Cayci
Journal:  Neuroradiol J       Date:  2019-08-28

2.  Texture analysis of conventional magnetic resonance imaging and diffusion-weighted imaging for distinguishing sinonasal non-Hodgkin's lymphoma from squamous cell carcinoma.

Authors:  Guo-Yi Su; Jun Liu; Xiao-Quan Xu; Mei-Ping Lu; Min Yin; Fei-Yun Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-22       Impact factor: 2.503

Review 3.  Maxillofacial lymphomas.

Authors:  David MacDonald; Montgomery Martin; Kerry Savage
Journal:  Br J Radiol       Date:  2021-01-06       Impact factor: 3.039

4.  MRI features of different types of sinonasan rhabdomyosarcomas: a series of eleven cases.

Authors:  Junjie Zeng; Lan Liu; Jiayong Li; Qiling Huang; Leiming Pi; Ke Jin
Journal:  Dentomaxillofac Radiol       Date:  2021-04-09       Impact factor: 2.419

5.  Differential diagnosis of sinonasal extranodal NK/T cell lymphoma and diffuse large B cell lymphoma on MRI.

Authors:  Yun Chen; Xinyan Wang; Long Li; Wei Li; Junfang Xian
Journal:  Neuroradiology       Date:  2020-06-19       Impact factor: 2.804

6.  Application Value of Real-Time Ultrasonic Elastograph with Serum Human Epididymis Protein 4, Interleukin-33, and Carbohydrate Antigen 153 in Diagnosis of Early Cervical Cancer.

Authors:  Maoping Guo; Lingling Liang; Litao Wu; Daolin Xie; Jian Li
Journal:  J Healthc Eng       Date:  2022-04-12       Impact factor: 3.822

7.  Immunoglobulin G4-Related Disease Involving the Pterygopalatine Fossa, Mimicking Invasive Aspergillosis: A Case Report and Literature Review.

Authors:  Jin Young Son; Jee Young Kim; Jin Hee Cho; Eun Jung Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.